TABLE 5.
Serum plasmalogen/phosphatide indices in ADNI-1/GO/2 Cohort: associations with CSF AD biomarkers
| CSF Total tau (Ttau) |
CSF Aβ1-42 |
Log10(CSF Ttau/CSF Aβ1-42) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Ratio/Index | β (95% CI) | P value | Q value | β (95% CI) | P value | Q value | β (95% CI) | P value | Q value |
| PBV | −6.994 (−10.049, −3.94) | 7.77E-06 | 3.11E-05 | 1.970 (−0.868, 4.807) | 0.173 | 0.694 | −0.041 (−0.058, −0.023) | 4.39E-06 | 1.76E-05 |
| PL-PX | −7.193 (−10.285, −4.101) | 5.55E-06 | 3.11E-05 | 2.048 (−0.826, 4.922) | 0.162 | 0.694 | −0.042 (−0.06, −0.025) | 2.73E-06 | 1.64E-05 |
| PL/PE | −0.038 (−3.205, 3.13) | 0.981 | 0.981 | 0.518 (−2.391, 3.428) | 0.727 | 0.988 | 0.000 (−0.018, 0.018) | 0.9664 | 0.9664 |
| PL205_224 | −5.11 (−8.096, −2.123) | 8.15E-04 | 2.44E-03 | 1.649 (−1.11, 4.407) | 0.241 | 0.724 | −0.029 (−0.046, −0.012) | 0.0009 | 0.0026 |
| PL205_226 | 0.589 (−2.507, 3.685) | 0.709 | 0.945 | 0.137 (−2.711, 2.984) | 0.925 | 0.988 | 0.006 (−0.012, 0.023) | 0.5157 | 0.9664 |
| PL226_224 | −7.543 (−10.653, −4.432) | 2.21E-06 | 2.65E-05 | 2.150 (−0.745, 5.045) | 0.145 | 0.694 | −0.045 (−0.062, −0.027) | 7.38E-07 | 8.86E-06 |
| PL226_PE226 | −0.238 (−3.409, 2.932) | 0.883 | 0.963 | 0.581 (−2.329, 3.492) | 0.695 | 0.988 | −0.002 (−0.02, 0.016) | 0.8097 | 0.9664 |
| PL205_PE226 | 0.302 (−2.81, 3.414) | 0.849 | 0.963 | 0.428 (−2.434, 3.289) | 0.769 | 0.988 | 0.003 (−0.015, 0.021) | 0.7322 | 0.9664 |
Abbreviations: CI, confidence interval; CSF, cerebrospinal fluid; PBV, plasmalogen biosynthesis value; PE, phosphatidylethanolamines; PL, plasmalogens; PL-PX, plasmalogen remodeling.